Doctolib Logo

Healthcare Clinic & Outpatient Practice Management · B2B SaaS Provider · B2C Consumer App / Platform

Doctolib

Healthcare booking and practice software platform for providers and patients.

Available information varies by company and source.

Profile record updated:

Company facts

Official name
DOCTOLIB SAS
Entity type
COMPANY
Founded
2013
Headquarters
France
Company size
1,001–5,000
Market cluster / sector
Healthcare Clinic & Outpatient Practice Management
Market role
B2B SaaS Provider · B2C Consumer App / Platform
Official website
doctolib.fr

What Doctolib does

Doctolib operates a two-sided digital health model. On one side, it offers free patient-facing search, booking and teleconsultation access to build demand and engagement. On the other, it sells subscription software to healthcare professionals, clinics and medical institutions for scheduling, practice management, patient communication and teleconsultation workflows. Value is created by connecting patient acquisition and appointment demand with provider workflow software, making the B2B product more useful as network density increases.

Category differentiation

Doctolib is a digital health booking, teleconsultation and provider workflow platform, not an adtech, martech or general-purpose marketing automation vendor. It competes with healthcare appointment and practice software platforms rather than media or commerce software providers.

Strategic context

AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.

Doctolib is a French digital health platform operating a patient appointment marketplace alongside subscription software for healthcare professionals. Patients use the web and mobile product to search for clinicians, book appointments, receive reminders and access teleconsultations, while clinics and practitioners use Doctolib Pro to manage calendars, bookings, patient communication and remote consultations. The company primarily makes money from recurring B2B subscriptions paid by healthcare professionals, clinics and healthcare institutions rather than from patients. Its commercial model combines a free consumer access layer with paid provider software, creating a two-sided network in which patient demand improves provider value and provider supply improves patient utility. Financially, it is a large private European scale-up backed by investors including Eurazeo, Bpifrance and General Atlantic, and it has expanded through acquisitions in France and Italy.

Business model & monetisation

Doctolib primarily monetises through recurring SaaS subscriptions charged to healthcare providers and institutions for Doctolib Pro, including scheduling, practice administration, patient communication and teleconsultation functionality. The patient-facing marketplace is free to use and is monetised indirectly by increasing provider demand and software adoption. Revenue is driven mainly by direct sales and subscription contracts, with possible ancillary onboarding, training and enterprise implementation services for larger organisations.

Provider subscriptions for practice management software
Software Subscription
Teleconsultation functionality within provider software
Software Subscription
Enterprise contracts with clinics and hospitals
Software Subscription
Onboarding, training or implementation support
Service Fee

Products & capabilities

Recorded products with linked evidence; content review pending.
ProductDescriptionSource
DoctolibDoctolib is a consumer-facing digital healthcare platform that allows patients to search for healthcare professionals and book appointments online via web and mobile applications. It operates a large directory of providers, offering availability visibility, appointment management, and integration with remote consultations. The platform is free for patients and acts as the primary acquisition and engagement layer for healthcare access.
Doctolib ProDoctolib Pro is a SaaS practice management platform designed for healthcare professionals and clinics to manage appointments, calendars, and patient interactions. It integrates directly with the public Doctolib marketplace, enabling providers to receive bookings, coordinate workflows, and streamline administrative processes. The software also supports teleconsultation and patient communication within a unified system.
  • “Practice management software Doctolib Pro”

  • “Doctolib employs a freemium B2B2C business model, with revenue primarily generated from healthcare providers.”

Video ConsultationVideo Consultation is Doctolib’s telemedicine product that enables secure remote consultations between patients and healthcare professionals. It is fully integrated with the Doctolib booking system, allowing appointments to transition seamlessly into virtual visits across web and mobile environments. The solution supports real-time video interactions tied to provider schedules and patient records.
  • “Video consultation - Teleconsultation”

  • “the teleconsultation service (Doctolib online appointment booking platform for Teleconsultation)”

POLARIS7 WORKSPACE

Go deeper on Doctolib and its market context

Access extended corporate structures, historical M&A and partnership links, technical footprint data, and automated Watchlist briefings grounded in primary sources.

  • Corporate & subsidiary hierarchy
  • Competitor & partner network
  • Automated Watchlist briefings

Competitors & alternatives

Track competitor shifts

Receive automated telemetry on strategic moves, acquisitions, and market share shifts across Doctolib's competitive landscape.

Monitor company
  • Clinician network and healthcare workflow platform monetised via enterprise tools.

  • Patient engagement and commerce software for medspas and clinics.

  • Wellness business software for scheduling, payments and customer engagement.

  • Ambulatory healthcare software for EHR, billing and patient engagement.

Recent recorded signals

Dates refer to the source publication. Older entries are historical context, not evidence of a new event.

  • Nvidia Invests in Four French Tech Companies

    AI · Recorded impact score: 4/5

    Nvidia has announced investments in four French technology companies during Jensen Huang's visit to Paris. The companies are Doctolib, a healthcare appointment platform; Genesis AI, a robotics startup; Pigment, a financial planning software maker; and Entalpic, a materials research startup. The deals are minority stakes, but the specific amounts and equity sizes were not disclosed. Nvidia's investment in Doctolib is intended to support its development of AI agents and a digital health companion. This move is part of Nvidia's broader commitment of nearly $10 billion to Europe's tech ecosystem, with plans to announce an additional $2 billion in European deals within a week. The investments have drawn criticism over potential circular financing, where AI firms use the funds to buy Nvidia chips, but Huang rejects these claims.

    • Nvidia invests in Doctolib, Genesis AI, Pigment, and Entalpic.
    • The investments are minority stakes; amounts undisclosed.
  • Nvidia invests in Doctolib, Pigment, Genesis AI, Entalpic

    AI Investment · Recorded impact score: 4/5

    European tech startups raised €15.8 billion in September, nearly five times August's €3.2 billion, with the UK attracting the largest share (46%). Mega-deals included Mistral's €3 billion Series D and Nscale's $3.36 billion convertible notes; even excluding these, funding tripled month-over-month. Nvidia continued its European expansion by announcing minority investments in four French startups (Doctolib, Genesis AI, Pigment, Entalpic) and five UK startups (Boltz, Foresight, Hiverge, Prima Mente, Riverlane), as part of nearly €9 billion in European commitments. CEO Jensen Huang also announced a $250 million compute donation to UK AI safety and research. Critics question circular financing, while Huang advocates continued dialogue with Chinese AI firms. These moves follow Nvidia's recent agreement to acquire Hugging Face for about $12.9 billion.

    • European startups raised €15.8 billion in September, nearly five times August's €3.2 billion.
    • Nvidia announced minority investments in four French (Doctolib, Genesis AI, Pigment, Entalpic) and five UK (Boltz, Foresight, Hiverge, Prima Mente, Riverlane) startups, with total European commitment near €9 billion.

Careers & open positions

Open positions indexed from verified career portals and applicant tracking systems.

PositionDepartmentLocationPosted
Software Engineering Intern - Fullstack(Intern)EngineeringParis, France
[Field Sales - FR] Account Executive -Toulouse(Mid-Level)SalesToulouse, France
Stage - Assistant Commercial - janvier 2027(Intern)SalesStrasbourg, France
AI Engineer Intern - Nantes(Intern)EngineeringNantes, France
AI Engineer Intern(Intern)EngineeringParis, France

Explore company relationships

Questions about Doctolib

What is Doctolib?

Doctolib is a French digital health platform that combines online medical appointment booking for patients with subscription practice software for healthcare providers.

Who uses Doctolib?

Patients use it to find and book healthcare appointments, while doctors, clinics and medical practices use Doctolib Pro to manage schedules, patient communication and teleconsultations.

How does Doctolib make money?

It mainly earns recurring subscription revenue from healthcare professionals and institutions that pay for its practice management and teleconsultation software.

Sources & coverage

This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.

2 publicly documented primary sources and citations linked across the market graph.

Start with a company or market. Track what changes.

Create your Polaris7 workspace to explore extended company profiles, organize relevant players into Watchlists, and receive focused briefings when material changes occur.